Gene · 2168
Papers3,436
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,436
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association Of Liver Fatty Acid Binding Protein With Acute Kidney Injury In Paediatric Patients After Cardiac Surgery. | J Ayub Med Coll Abbottabad | 2022 | 36414576 | PubTator, text mining | PubMed |
| Therapeutic mechanism and clinical application of Chinese herbal medicine against diabetic kidney disease. | Front Pharmacol | 2022 | 36408255 | PubTator, text mining | PubMed |
| Mechanisms underlying the therapeutic effects of 4-octyl itaconate in treating sepsis based on network pharmacology and molecular docking. | Front Genet | 2022 | 36406124 | PubTator, text mining | PubMed |
| Roles and crosstalks of macrophages in diabetic nephropathy. | Front Immunol | 2022 | 36405700 | PubTator, text mining | PubMed |
| Myokines: Novel therapeutic targets for diabetic nephropathy. | Front Endocrinol (Lausanne) | 2022 | 36387916 | PubTator, text mining | PubMed |
| Lipid droplet - mitochondria coupling: A novel lipid metabolism regulatory hub in diabetic nephropathy. | Front Endocrinol (Lausanne) | 2022 | 36387849 | PubTator, text mining | PubMed |
| Plasma neutrophil gelatinase-associated lipocalin (NGAL): A candidate biomarker to detect early acute kidney injury (AKI) for at-risk intensive care admissions. | J Family Med Prim Care | 2022 | 36387665 | PubTator, text mining | PubMed |
| Models predict change in plasma triglyceride concentrations and long-chain n-3 polyunsaturated fatty acid proportions in healthy participants after fish oil intervention. | Front Nutr | 2022 | 36386924 | PubTator, text mining | PubMed |
| March hemoglobinuria progressed to acute kidney injury after kendo practice: a case report. | BMC Nephrol | 2022 | 36384502 | PubTator, text mining | PubMed |
| Urinary liver-type fatty acid-binding protein: A hemodynamic index during extracorporeal membrane oxygenation. | Clin Case Rep | 2022 | 36381026 | PubTator, text mining | PubMed |
| Comparative accuracy of biomarkers for the prediction of hospital-acquired acute kidney injury: a systematic review and meta-analysis. | Crit Care | 2022 | 36371256 | PubTator, text mining | PubMed |
| Mouse models of Kras activation in gastric cancer. | Exp Mol Med | 2022 | 36369466 | PubTator, text mining | PubMed |
| Optimum Post-Discharge Care of Acute Kidney Injury (AKI) Survivors. | J Clin Med | 2022 | 36362503 | PubTator, text mining | PubMed |
| Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Ocular Graft-Versus-Host Disease. | Int J Mol Sci | 2022 | 36362040 | PubTator, text mining | PubMed |
| Insights into the Genetics and Signaling Pathways in Maturity-Onset Diabetes of the Young. | Int J Mol Sci | 2022 | 36361703 | PubTator, text mining | PubMed |
| Renoprotective Effects of Luteolin: Therapeutic Potential for COVID-19-Associated Acute Kidney Injuries. | Biomolecules | 2022 | 36358895 | PubTator, text mining | PubMed |
| Role of AMPK-SREBP Signaling in Regulating Fatty Acid Binding-4 (FABP4) Expression following Ethanol Metabolism. | Biology (Basel) | 2022 | 36358315 | PubTator, text mining | PubMed |
| Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries. | J Biomed Sci | 2022 | 36357929 | PubTator, text mining | PubMed |
| NIK/MAP3K14 in hepatocytes orchestrates NASH to hepatocellular carcinoma progression via JAK2/STAT5 inhibition. | Mol Metab | 2022 | 36356831 | PubTator, text mining | PubMed |
| Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition. | Pharmaceuticals (Basel) | 2022 | 36355506 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2168/papers?page=34